Difference between revisions of "RXN-12872"

From metabolic_network
Jump to: navigation, search
(Created page with "Category:Reaction == Reaction [http://metacyc.org/META/NEW-IMAGE?object=GALACTURIDYLYLTRANS-RXN GALACTURIDYLYLTRANS-RXN] == * direction: ** REVERSIBLE * ec number: ** [htt...")
(Created page with "Category:Metabolite == Metabolite [http://metacyc.org/META/NEW-IMAGE?object=2-3-CARBOXY-3-METHYLAMMONIOPROPYL-L- 2-3-CARBOXY-3-METHYLAMMONIOPROPYL-L-] == * common name: **...")
Line 1: Line 1:
[[Category:Reaction]]
+
[[Category:Metabolite]]
== Reaction [http://metacyc.org/META/NEW-IMAGE?object=GALACTURIDYLYLTRANS-RXN GALACTURIDYLYLTRANS-RXN] ==
+
== Metabolite [http://metacyc.org/META/NEW-IMAGE?object=2-3-CARBOXY-3-METHYLAMMONIOPROPYL-L- 2-3-CARBOXY-3-METHYLAMMONIOPROPYL-L-] ==
* direction:
+
* common name:
** REVERSIBLE
+
** a 2-[(3S)-3-carboxy-3-(methylammonio)propyl]-L-histidine-[translation elongation factor 2]
* ec number:
+
** [http://enzyme.expasy.org/EC/2.7.7.12 EC-2.7.7.12]
+
 
* Synonym(s):
 
* Synonym(s):
 +
** a [3-[[4-(2-amino-2-carboxy-ethyl)-1H-imidazol-2-yl]]-1-carboxy- propyl]-methyl-ammonium
 +
** a 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine
 +
** 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine in eEF-2
  
== Reaction Formula ==
+
== Reaction(s) known to consume the compound ==
* With identifiers:
+
* [[RXN-11374]]
** 1 [[GALACTOSE-1P]][c] '''+''' 1 [[CPD-12575]][c] '''<=>''' 1 [[GLC-1-P]][c] '''+''' 1 [[CPD-14553]][c]
+
== Reaction(s) known to produce the compound ==
* With common name(s):
+
* [[RXN-11370]]
** 1 &alpha;-D-galactose 1-phosphate[c] '''+''' 1 UDP-&alpha;-D-glucose[c] '''<=>''' 1 &alpha;-D-glucopyranose 1-phosphate[c] '''+''' 1 UDP-&alpha;-D-galactose[c]
+
== Reaction(s) of unknown directionality ==
 
+
== Genes associated with this reaction  ==
+
Genes have been associated with this reaction based on different elements listed below.
+
* [[Tiso_gene_2435]]
+
** [[pantograph]]-[[esiliculosus]]
+
== Pathways  ==
+
* [[PWY-6317]], D-galactose degradation I (Leloir pathway): [http://metacyc.org/META/NEW-IMAGE?object=PWY-6317 PWY-6317]
+
** '''5''' reactions found over '''5''' reactions in the full pathway
+
* [[PWY66-422]], D-galactose degradation V (Leloir pathway): [http://metacyc.org/META/NEW-IMAGE?object=PWY66-422 PWY66-422]
+
** '''5''' reactions found over '''5''' reactions in the full pathway
+
* [[PWY-6527]], stachyose degradation: [http://metacyc.org/META/NEW-IMAGE?object=PWY-6527 PWY-6527]
+
** '''7''' reactions found over '''7''' reactions in the full pathway
+
== Reconstruction information  ==
+
* Category: [[orthology]]
+
** Source: [[orthology-esiliculosus]]
+
*** Tool: [[pantograph]]
+
* Category: [[annotation]]
+
** Source: [[annotation-experimental_annotation]]
+
*** Tool: [[pathwaytools]]
+
** Source: [[annotation-in-silico_annotation]]
+
*** Tool: [[pathwaytools]]
+
 
== External links  ==
 
== External links  ==
* RHEA:
+
{{#set: common name=a 2-[(3S)-3-carboxy-3-(methylammonio)propyl]-L-histidine-[translation elongation factor 2]}}
** [http://www.ebi.ac.uk/rhea/reaction.xhtml?id=13989 13989]
+
{{#set: common name=a [3-[[4-(2-amino-2-carboxy-ethyl)-1H-imidazol-2-yl]]-1-carboxy- propyl]-methyl-ammonium|a 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine|2-[3-carboxy-3-(methylammonio)propyl]-L-histidine in eEF-2}}
* LIGAND-RXN:
+
{{#set: consumed by=RXN-11374}}
** [http://www.genome.jp/dbget-bin/www_bget?R00955 R00955]
+
{{#set: produced by=RXN-11370}}
* UNIPROT:
+
** [http://www.uniprot.org/uniprot/P43424 P43424]
+
** [http://www.uniprot.org/uniprot/P31764 P31764]
+
** [http://www.uniprot.org/uniprot/P07902 P07902]
+
** [http://www.uniprot.org/uniprot/P08431 P08431]
+
** [http://www.uniprot.org/uniprot/P09148 P09148]
+
** [http://www.uniprot.org/uniprot/P13212 P13212]
+
** [http://www.uniprot.org/uniprot/P09580 P09580]
+
{{#set: direction=REVERSIBLE}}
+
{{#set: ec number=EC-2.7.7.12}}
+
{{#set: gene associated=Tiso_gene_2435}}
+
{{#set: in pathway=PWY-6317|PWY66-422|PWY-6527}}
+
{{#set: reconstruction category=orthology|annotation}}
+
{{#set: reconstruction source=annotation-experimental_annotation|annotation-in-silico_annotation|orthology-esiliculosus}}
+
{{#set: reconstruction tool=pantograph|pathwaytools}}
+

Revision as of 16:46, 21 March 2018

Metabolite 2-3-CARBOXY-3-METHYLAMMONIOPROPYL-L-

  • common name:
    • a 2-[(3S)-3-carboxy-3-(methylammonio)propyl]-L-histidine-[translation elongation factor 2]
  • Synonym(s):

Reaction(s) known to consume the compound

Reaction(s) known to produce the compound

Reaction(s) of unknown directionality

External links

"a 2-[(3S)-3-carboxy-3-(methylammonio)propyl]-L-histidine-[translation elongation factor 2" cannot be used as a page name in this wiki.
  • "a [3-4-(2-amino-2-carboxy-ethyl)-1H-imidazol-2-yl-1-carboxy- propyl]-methyl-ammonium" cannot be used as a page name in this wiki.
  • "a 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine" cannot be used as a page name in this wiki.
  • "2-[3-carboxy-3-(methylammonio)propyl]-L-histidine in eEF-2" cannot be used as a page name in this wiki.